SEC Filing Details
SEC Filing Details
Document Details
Form
Filing Date
Nov 15, 2024
Document Date
Nov 6, 2024
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Evoke Pharma, Inc.
Issuer
Evoke Pharma Inc
Filer
NANTAHALA CAPITAL MANAGEMENT, LLC